About 9 percent of the U.S. population is affected by atopic dermatitis, and that percentage is growing according to the American Academy of Allergy, Asthma and Immunology (AAAAI).
SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata
“My Skin My Story” Provides Creative Outlet for Young Patients With Eczema